Page last updated: 2024-10-20

selenic acid and Prostatic Neoplasms

selenic acid has been researched along with Prostatic Neoplasms in 3 studies

Selenic Acid: A strong dibasic acid with the molecular formula H2SeO4. Included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research Excerpts

ExcerptRelevanceReference
" Sodium selenate is a small, water-soluble, orally bioavailable activator of PP2A phosphatase with anti-angiogenic properties."2.75Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer. ( Corcoran, NM; Costello, AJ; Hovens, CM; Michael, M; Rosenthal, MA, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corcoran, NM1
Hovens, CM1
Michael, M1
Rosenthal, MA1
Costello, AJ1
Holmstrom, A1
Wu, RT1
Zeng, H1
Lei, KY1
Cheng, WH1
Lipinski, B1

Trials

1 trial available for selenic acid and Prostatic Neoplasms

ArticleYear
Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.
    British journal of cancer, 2010, Aug-10, Volume: 103, Issue:4

    Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Dose-Response Relationship, Drug; Humans; Male

2010

Other Studies

2 other studies available for selenic acid and Prostatic Neoplasms

ArticleYear
Nutritional and supranutritional levels of selenate differentially suppress prostate tumor growth in adult but not young nude mice.
    The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:9

    Topics: Aging; Animals; Anticarcinogenic Agents; Cell Line, Tumor; Dietary Supplements; Humans; Male; Mice;

2012
Re: Science peels the onion of selenium effects on prostate carcinogenesis.
    Journal of the National Cancer Institute, 2004, Nov-03, Volume: 96, Issue:21

    Topics: Anticarcinogenic Agents; Antioxidants; Humans; Male; Oxidation-Reduction; Prostatic Neoplasms; Selen

2004